CordovaCann (LVRLF) Return on Capital Employed (2018 - 2019)
CordovaCann (LVRLF) recorded quarterly Return on Capital Employed of 1914.87% in Q2 2019, down 842.88% quarter-over-quarter from 203.09% in Q2 2018, and down 171178.0% on a YoY basis from N/an in Q2 2018.
CordovaCann (LVRLF) Return on Capital Employed (2018 - 2019) Analysis & Trends
CordovaCann's Return on Capital Employed history runs 2 years deep, the most recent figure standing at 1914.87% for Q2 2019.
- In Q2 2019, Return on Capital Employed fell 171178.0% year-over-year to 1914.87%; the TTM figure through Jun 2019 stood at 1914.87% (down 171178.0% YoY), while the FY2025 annual figure was 20.02%, up 10061.0% from the prior year.
- Return on Capital Employed was 1914.87% for Q2 2019 at CordovaCann, down from 203.09% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 203.09% in Q2 2018 to a low of 1914.87% in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | CordovaCann | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -1,914.87% |
| Jun 30, 2018 | -203.09% |